Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells

Area of Science:

• Genetics
• Epigenetics
• Cancer Biology

Background:

• Genomic imprinting regulates gene expression based on parental origin.
• Loss of imprinting (LOI) for the Insulin-like Growth Factor 2 (IGF2) gene is frequently observed in various cancers.
• Previous studies lacked cellular-level resolution, leaving uncertainty about imprinting heterogeneity within tumors.

Purpose of the Study:

• To investigate the imprinting status of IGF2 and H19 at the cellular level within the JEG-3 choriocarcinoma cell line.
• To determine if loss of IGF2 imprinting in neoplastic cells reflects random imprinting patterns.
• To explore the relationship between IGF2 and H19 imprinting and allele usage.

Main Methods:

• Analysis of IGF2 and H19 imprinting patterns in individual cell populations of the JEG-3 cell line.
• Assessment of IGF2 and H19 imprinting status in JEG-3-derived tumors grown in nude mice.
• Examination of promoter-specific IGF2 allele usage in JEG-3 cell subclones.

Main Results:

• JEG-3 cell populations exhibit heterogeneous imprinting patterns for both IGF2 and H19.
• A lack of correlation between IGF2 and H19 imprinting suggests functional loss of regional parental imprints.
• JEG-3 subclones show varied promoter-specific IGF2 allele usage.
• H19 and IGF2 imprinting were differentially modulated in vivo.
• Allele-specific expression of IGF2 was observed in the absence of a detectable parental imprint.

Conclusions:

• Heterogeneity in imprinting patterns exists at the cellular level within tumors.
• Biallelic expression of IGF2 does not always equate to a loss of imprinting.
• Allele-specific expression of IGF2 can occur independently of established parental imprinting.
• Caution is advised when interpreting biallelic expression as solely 'loss of imprinting'.